The study findings demonstrate diverse neurodevelopmental profiles in treated children with/at-risk of spinal muscular atrophy type 1 associated with the magnitude and duration of SMN deficiency. The gene discussed is SMN1; the disease is hyperinsulinemic hypoglycemia, familial, 4.